PT95093A - Metodos para a culturizacao de hvc em celulas eucarioticas - Google Patents

Metodos para a culturizacao de hvc em celulas eucarioticas

Info

Publication number
PT95093A
PT95093A PT95093A PT9509390A PT95093A PT 95093 A PT95093 A PT 95093A PT 95093 A PT95093 A PT 95093A PT 9509390 A PT9509390 A PT 9509390A PT 95093 A PT95093 A PT 95093A
Authority
PT
Portugal
Prior art keywords
culturization
hvc
methods
cells
eucariotic
Prior art date
Application number
PT95093A
Other languages
English (en)
Other versions
PT95093B (pt
Inventor
Amy J Weiner
Kathelyn S Steimer
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23576300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT95093(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of PT95093A publication Critical patent/PT95093A/pt
Publication of PT95093B publication Critical patent/PT95093B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT95093A 1989-08-25 1990-08-24 Metodos para a culturizacao de hvc em celulas eucarioticas PT95093B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39866789A 1989-08-25 1989-08-25

Publications (2)

Publication Number Publication Date
PT95093A true PT95093A (pt) 1991-05-22
PT95093B PT95093B (pt) 1997-11-28

Family

ID=23576300

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95093A PT95093B (pt) 1989-08-25 1990-08-24 Metodos para a culturizacao de hvc em celulas eucarioticas

Country Status (12)

Country Link
EP (1) EP0414475B1 (pt)
JP (3) JPH05502156A (pt)
AT (1) ATE161041T1 (pt)
AU (1) AU655156B2 (pt)
CA (1) CA2064705C (pt)
DE (1) DE69031791T2 (pt)
DK (1) DK0414475T3 (pt)
ES (1) ES2110411T3 (pt)
GR (1) GR3026114T3 (pt)
IE (1) IE903097A1 (pt)
PT (1) PT95093B (pt)
WO (1) WO1991002820A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
IT1242183B (it) 1989-12-18 1994-02-16 Wellcome Found Polipeptidi del virus dell'epatite non-a e non-b, post-trasfusionali, procedimento di produzione e corredo per il saggio dei relativi acidi nucleici virali.
AU7672991A (en) * 1990-04-03 1991-10-30 Southwest Foundation For Biomedical Research Purified hcv and hcv proteins and peptides
AU7679491A (en) * 1990-04-04 1991-10-30 Protos, Inc. Hepatitis c virus protease inhibitors
US5443965A (en) * 1990-04-06 1995-08-22 Genelabs Incorporated Hepatitis C virus epitopes
US5747339A (en) 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
CA2065690A1 (en) * 1991-04-10 1992-10-11 Hiroaki Okamoto Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides
US5428145A (en) * 1991-08-09 1995-06-27 Immuno Japan, Inc. Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
CA2123875C (en) 1991-11-21 2005-05-24 Peter Simmons Hepatitis-c virus testing
US5552310A (en) * 1992-06-12 1996-09-03 Hiroshi Yoshikura Replication of hepatitis C virus genome and identification of virus having high infectivity
AU6943994A (en) * 1993-05-04 1994-11-21 United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hepatitis c virus cell propagation and related methods
US5840565A (en) 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5851758A (en) * 1995-10-25 1998-12-22 Childrens Research Institute Cytopathic replication of hepatitis C virus in a new cell line
US6242187B1 (en) 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
AP9801360A0 (en) * 1996-01-29 1998-12-31 Virologic Incorporated Compositions and methods ofr determining anti-viral drug susceptibility and resistance and anti-viral drug screening.
DE69739268D1 (de) 1996-11-08 2009-04-02 Us Gov Health & Human Serv Herstellung und reinigung von hepatitis c virus-ähnlichen partikeln
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
AT407256B (de) * 1998-06-24 2001-02-26 Immuno Ag Hepatitis c-virus positive endometriale zelllinie
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
WO2002014362A2 (en) 2000-08-17 2002-02-21 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
RU2286172C2 (ru) 2000-08-17 2006-10-27 Трипеп Аб Вакцины, содержащие рибавирин, и способы их использования
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
WO2007031867A2 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-stru tural ns3/4a fusion gene
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
US20090214593A1 (en) 2007-08-16 2009-08-27 Tripep Ab Immunogen platform
GB201119011D0 (en) * 2011-11-03 2011-12-14 Queen Mary Innovation Ltd Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
EP0071640B1 (en) * 1981-02-11 1986-06-04 Connaught Laboratories Incorporated Non-a, non-b hepatitis virus
AU613310B2 (en) * 1986-04-01 1991-08-01 Genelabs Incorporated Immortalized virus-specific tissue cells
EP0318216B2 (en) * 1987-11-18 2001-08-29 Chiron Corporation NANBV diagnostics

Also Published As

Publication number Publication date
JPH05502156A (ja) 1993-04-22
EP0414475A1 (en) 1991-02-27
JP2001314192A (ja) 2001-11-13
AU6344990A (en) 1991-04-03
PT95093B (pt) 1997-11-28
CA2064705A1 (en) 1991-02-26
DE69031791D1 (de) 1998-01-22
EP0414475B1 (en) 1997-12-10
DE69031791T2 (de) 1998-04-02
ES2110411T3 (es) 1998-02-16
ATE161041T1 (de) 1997-12-15
CA2064705C (en) 1999-04-06
DK0414475T3 (da) 1998-02-09
IE903097A1 (en) 1991-02-27
WO1991002820A1 (en) 1991-03-07
GR3026114T3 (en) 1998-05-29
JP2004049235A (ja) 2004-02-19
AU655156B2 (en) 1994-12-08

Similar Documents

Publication Publication Date Title
PT95093A (pt) Metodos para a culturizacao de hvc em celulas eucarioticas
DE3784484D1 (de) Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz.
IL73428A0 (en) Anti-idiotype antibodies against a tumor or virus,method and cell lines for producing them and compositions containing them
DE59209058D1 (de) Kultivierung von Vero-Zellen
JPS5610615A (en) Premixture burner actuation method and burner for executing same
BR8400588A (pt) Forno de fusao por inducao em alta frequencia e processo de preparacao de materiais ceramicos,por fusao,por inducao em alta frequencia
MY101236A (en) Grid ceiling
DE3789487D1 (de) Vorrichtung zur Erzeugung von Elektronenstrahlen.
EP0019218A3 (en) Influenza virus vaccines, process for preparing them, process for propagating influenza viruses and cell culture inoculated with influenza virus
DE3068528D1 (en) Process for propagating human hepatitis a virus in in vitro cell culture
DE69021496D1 (de) Integrierter Prozess zur Produktion von Diisopropylether und Benzin.
ES2177531T3 (es) Receptor de lipoproteinas de baja densidad (ldl), su produccion y su utilizacion.
DE3774308D1 (de) Verfahren zum herstellen von brennbaren gegenstaenden durch tiefziehen von brennbaren papierscheiben mit einer elastischen patrize und vorrichtung zum durchfuehren des verfahrens.
DK713188A (da) Fremgangsmaade til fremstilling af pregneno-oxazoliner
DK628188D0 (da) Protein og fremgangsmaade til fremstilling deraf
ES2043764T3 (es) Procedimiento para la preparacion de polimeros acrilicos imidizados.
DK0433845T3 (da) Fremgangsmåde til fremstilling af 2-acylamino-9-acyl-6-halogen-puriner
ATE219512T1 (de) Rinderovarzellinie (frov) zur virusvermehrung
JPS55126247A (en) Fixing method for photomask substrate
SE9303219L (sv) Containerok
FR2585722B1 (fr) Co-cultures d'hepatocytes et de cellules epitheliales de foie traitees
GB1105179A (en) Improvements in or relating to propagating human hepatitis virus
IT1261514B (it) Procedimento per la propagazione in vitro del virus dell'epatite c in colture cellulari animali non linfoblastoidi e relativo prodotto
ATE86120T1 (de) Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz.
DK107493A (da) Vektor for udtrykkelse i gaer, bestaaende af et fremmed dna-segment og en fremgangsmaade til syntese af fremmede proteiner ved hjaelp af en saadan vektor

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19901214

FG3A Patent granted, date of granting

Effective date: 19970826

PD4A Change of proprietorship

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC., US

Effective date: 20080215

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120827